Zydus Cadila launches Ramelteon tablets in US to treat insomnia Medical Dialogues Bureau25 July 2019 11:23 AM ISTIn a BSE filing, Zydus Cadila announced the "launch of Ramelteon tablets, 8 mg upon receiving the final approval from the USFDA. Ramelteon is a...
Torrent Pharma Q1 net profit up 33 percent to Rs 216 crore Medical Dialogues Bureau24 July 2019 9:30 AM ISTThe firm's India business was up nine per cent year-on-year to Rs 907 crore for the quarter. The US revenues at Rs 376 crore were up by 13 per cent...
Laurus Labs, Rising Pharma launches neuropathic pain capsules in US Medical Dialogues Bureau23 July 2019 9:30 AM ISTRising Pharmaceuticals has launched a generic version of Lyrica capsules, in the strengths of 25 mg, 50 mg, 75 mg, 100 mg, 150 mg, 200 mg, 225 mg and...
Zydus Cadila arm gets USFDA nod for generic version of Adderall XR capsules in US Medical Dialogues Bureau21 July 2019 10:00 AM ISTThe product is a generic version of Adderall XR capsules and will be manufactured at Nesher Pharmaceuticals' manufacturing facility at St Louis in the...
Patients with NASH have been enrolled in 3 phase III trials of Saroglitazar, says Zydus Cadila Medical Dialogues Bureau18 July 2019 9:17 AM IST"Patients with NASH have been enrolled in these trials across clinical sites in India and Mexico," Cadila Healthcare, the listed entity of the group,...
Natco Pharma gets zero USFDA observations for Chennai facility Medical Dialogues Bureau16 July 2019 9:30 AM ISTNatco Pharma announced "successful completion of regulatory inspection from the US Food and Drug Administration (USFDA) for its active pharmaceutical...
Sun Pharma Research Arm- SPARC gets USFDA orphan drug designation for novel kinase inhibitor Medical Dialogues Bureau9 July 2019 12:49 PM ISTMumbai: Sun Pharma Advanced Research Company (SPARC) on Monday said the US health regulator has given orphan drug designation to its novel kinase...
Zydus Cadila gets USFDA nod for generic Misoprostol tablets to treat ulcers Medical Dialogues Bureau5 July 2019 11:52 AM ISTNew Delhi: Drug firm Zydus Cadila Wednesday said it has received the final nod from the US health regulator to market its generic Misoprostol tablets...
Dr Reddys gets two USFDA observations for Vizag plants Farhat Nasim24 Jun 2019 11:09 AM ISTHyderabad: City-based Dr Reddy's Laboratories (Dr Reddys/ DRL) has reportedly fallen under the US health regulator's scanner. The company has been...
Cadila Healthcare gets EIR report on Ahmedabad SEZ facility Medical Dialogues Bureau18 Jun 2019 1:57 PM ISTNew Delhi: Drug firm Cadila Healthcare Monday said it has received establishment inspection report from the US health regulator with voluntary action...
Yes Bank reduces stake in Fortis Healthcare by selling shares worth over Rs 1.51 crore Farhat Nasim12 Jun 2019 11:29 AM ISTNew Delhi: Yes Bank has reduced its stake in Fortis healthcare (FHL) by around 2 per cent by selling over 1.51 crore shares of the company in various...
Natco Pharma- Kothur facility gets 9 observations from USFDA Medical Dialogues Bureau7 Jun 2019 2:21 PM ISTNEW DELHI: Natco Pharma Thursday said the US health regulator has made nine observations after the completion of inspection of its Kothur formulation...
